Propanc Biopharma
PPCB
#11204
Rank
A$2.81 M
Marketcap
A$2.69
Share price
3.19%
Change (1 day)
114.42%
Change (1 year)

EPS for Propanc Biopharma (PPCB)

EPS in 2026 (TTM): A-$536.71

According to Propanc Biopharma's latest financial reports the company's current EPS (TTM) is A-$508.76. In 2025 the company made an earnings per share (EPS) of A-$560.84 an increase over its 2024 EPS that were of A-$9,536.

EPS history for Propanc Biopharma from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$536.71-4.3%
2025A-$560.84-94.12%
2024A-$9,536-99.19%
2023A-$1,181,007-30.17%
2022A-$1,691,304139834.46%
2021A-$1,209-95.65%
2020A-$27,761-99.68%
2019A-$8,699,7447426.04%
2018A-$115,595-91.25%
2017A-$1,320,691-53.55%
2016A-$2,843,43210.3%
2015A-$2,577,994119409.17%
2014A-$2,157-44.08%
2013A-$3,858-87.03%
2012A-$29,733-99.09%
2011A-$3,251,207